Pfizer, Inc. vs Revolution Medicines, Inc. — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
5.1
Bearish
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
RVMD
100% of 21 covering analysts have a positive rating.
⚠ low return on equity (-58%).
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $174.30 (+25.0%)
20 analysts
Fundamentals
PFE
RVMD
19.4×
Trailing P/E
—
9.4×
Forward P/E
-26.6×
12.4%
Profit Margin
0.0%
75.8%
Gross Margin
0.0%
8.9%
ROE
-58.1%
-1.2%
Revenue Growth
—
—
Earnings Growth
—
0.39
Beta
1.01
—
Price / Book
—
$149.8B
Market Cap
$29.7B
$22 – $29
52-Week Range
$34 – $156
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →